INCOG BioPharma is a fill/finish CDMO providing end-to-end solutions for clinical through commercial phase sterile injectable drug products for the global biopharmaceutical market. Our facility is FDA-approved and Annex 1-compliant and uses the latest technology to provide tailored manufacturing solutions. We fill high-value biologics and peptides into syringes, vials, and cartridges, and offer device assembly (including APFS and autoinjector), final packaging solutions, and in-house analytics.
Our experienced team creates value for customers by driving accelerated timelines, simplifying complex supply chains, which enables drug developers to focus on advancing their therapies to market with speed and confidence.
We aim to be a strategic CDMO partner for market-leading biopharmaceutical companies who are looking to collaborate across multiple programs over the long-term.
To create a better path to market for life-saving drugs by serving our customers in extra-ordinary ways and cultivating a high-performance organization that engages the full capabilities of our team and partners.
All In
• Patient impact motivates and inspires us
• Teammates bring a positive attitude & best efforts, every day
• Company commits to the personal and professional growth and success of every teammate
Lean Forward
• Have a bias for action
• Be service-centric and solution-oriented
• Welcome challenging projects and timelines
• Tackle tough conversations head-on
• Work to be flexible within well-designed systems and protocols
Pull for the Team
• Put customers’ success first
• Treat others with respect
We directly contribute to better patient outcomes by helping innovator companies bring groundbreaking drugs to address critical health challenges.
Our unwavering commitment to refining processes and enhancing quality isn't just about efficiency; it's about delivering better, safer products more quickly, particularly crucial in high-priority areas and times of crisis.
Recognizing that our ability to change lives goes beyond our products, we actively give back to our community through fundraising, volunteering, and Donations.
Excellence isn’t just a goal; it’s the fundamental standard guiding everything we do. We were built with the express purpose of being better—pushing the limits of what’s possible in biopharmaceutical manufacturing through both cutting-edge operations and the dedicated people who drive them.
Excellence isn’t just a goal; it’s the fundamental standard guiding everything we do. We were built with the express purpose of being better—pushing the limits of what’s possible in biopharmaceutical manufacturing through both cutting-edge operations and the dedicated people who drive them.
Excellence isn’t just a goal; it’s the fundamental standard guiding everything we do. We were built with the express purpose of being better—pushing the limits of what’s possible in biopharmaceutical manufacturing through both cutting-edge operations and the dedicated people who drive them.
On a bike ride in Maui, Cory Lewis decides to make a move: create a CDMO that uses the best elements of sterile injectable drug manufacturing and the brightest industry minds to deliver a different, faster, better experience while keeping patients’ best interests at heart.
June: INCOG BioPharma Services is founded on June 8; the initial investment is used to acquire the property for its first site in Fishers, Indiana, a manufacturing facility for sterile injectable drug products.
Construction of Building One begins with a focus on flexibility and scalability, catering to the needs of biopharmaceutical companies who focus on high-value biologics and peptides.
Building One is completed in less than 12 months, despite innumerable challenges brought on by the Covid-19 pandemic. The 94-000ft2 space is dedicated to formulation and filling, laboratory testing and finished product storage.
Building One is equipped with an OPTIMA MultiUse filling line, driving up to 40 million units of annual capacity for pre-filled syringes, cartridges and vials; QC labs are ready and operational.
Fill Line 1 is cGMP qualified with its first media fill campaign; INCOG initiates its first tech transfer to support a commercially approved product.
Customer manufacturing kicks off with a PPQ campaign supporting a drug product in 1ml long syringes.
The addition of a second OPTIMA filling line is announced; high-speed line prepares INCOG to drive scale with an additional 100 million untis of syringe and cartridge capacity.
A true end-to-end CDMO partner, we support your product’s evolution from concept to clinical readiness to commercial delivery.
Designing a culture that informs our brand promise: Committed to Excellence. Driven by Purpose. United by People
Designing a culture that informs our brand promise: Committed to Excellence. Driven by Purpose. United by People
Designing a culture that informs our brand promise: Committed to Excellence. Driven by Purpose. United by People
Reach out to one of our team members using the form and don’t forget to keep across the INCOG journey by following us on online.
A new standard of CDMO. Designed to deliver better. Built on trust.
